As a result of the entry into force of Implementing Regulation (EU) 2022/782 of 18 May 2022 concerning the non-renewal of isopyrazam approval, Anses will withdraw […]
As a result of the entry into force of Implementing Regulation (EU) 2021/2081 of 26 November 2021 and Implementing Regulation (EU) 2022/94 of 24 January 2022 […]
As a result of the entry into force of Implementing Regulation (EU) 2021/1379 of 19 August 2021 concerning the non-renewal of famoxadone approval, the last authorisation […]